Development and validation of prediction models for mechanical ventilation, renal replacement therapy, and readmission in COVID-19 patients

Abstract Objective Coronavirus disease 2019 (COVID-19) patients are at risk for resource-intensive outcomes including mechanical ventilation (MV), renal replacement therapy (RRT), and readmission. Accurate outcome prognostication could facilitate hospital resource allocation. We develop and validate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Medical Informatics Association : JAMIA Jg. 28; H. 7; S. 1480 - 1488
Hauptverfasser: Rodriguez, Victor Alfonso, Bhave, Shreyas, Chen, Ruijun, Pang, Chao, Hripcsak, George, Sengupta, Soumitra, Elhadad, Noemie, Green, Robert, Adelman, Jason, Metitiri, Katherine Schlosser, Elias, Pierre, Groves, Holden, Mohan, Sumit, Natarajan, Karthik, Perotte, Adler
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England Oxford University Press 14.07.2021
Schlagworte:
ISSN:1527-974X, 1527-974X
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Abstract Objective Coronavirus disease 2019 (COVID-19) patients are at risk for resource-intensive outcomes including mechanical ventilation (MV), renal replacement therapy (RRT), and readmission. Accurate outcome prognostication could facilitate hospital resource allocation. We develop and validate predictive models for each outcome using retrospective electronic health record data for COVID-19 patients treated between March 2 and May 6, 2020. Materials and Methods For each outcome, we trained 3 classes of prediction models using clinical data for a cohort of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2)–positive patients (n = 2256). Cross-validation was used to select the best-performing models per the areas under the receiver-operating characteristic and precision-recall curves. Models were validated using a held-out cohort (n = 855). We measured each model’s calibration and evaluated feature importances to interpret model output. Results The predictive performance for our selected models on the held-out cohort was as follows: area under the receiver-operating characteristic curve—MV 0.743 (95% CI, 0.682-0.812), RRT 0.847 (95% CI, 0.772-0.936), readmission 0.871 (95% CI, 0.830-0.917); area under the precision-recall curve—MV 0.137 (95% CI, 0.047-0.175), RRT 0.325 (95% CI, 0.117-0.497), readmission 0.504 (95% CI, 0.388-0.604). Predictions were well calibrated, and the most important features within each model were consistent with clinical intuition. Discussion Our models produce performant, well-calibrated, and interpretable predictions for COVID-19 patients at risk for the target outcomes. They demonstrate the potential to accurately estimate outcome prognosis in resource-constrained care sites managing COVID-19 patients. Conclusions We develop and validate prognostic models targeting MV, RRT, and readmission for hospitalized COVID-19 patients which produce accurate, interpretable predictions. Additional external validation studies are needed to further verify the generalizability of our results.
AbstractList Abstract Objective Coronavirus disease 2019 (COVID-19) patients are at risk for resource-intensive outcomes including mechanical ventilation (MV), renal replacement therapy (RRT), and readmission. Accurate outcome prognostication could facilitate hospital resource allocation. We develop and validate predictive models for each outcome using retrospective electronic health record data for COVID-19 patients treated between March 2 and May 6, 2020. Materials and Methods For each outcome, we trained 3 classes of prediction models using clinical data for a cohort of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2)–positive patients (n = 2256). Cross-validation was used to select the best-performing models per the areas under the receiver-operating characteristic and precision-recall curves. Models were validated using a held-out cohort (n = 855). We measured each model’s calibration and evaluated feature importances to interpret model output. Results The predictive performance for our selected models on the held-out cohort was as follows: area under the receiver-operating characteristic curve—MV 0.743 (95% CI, 0.682-0.812), RRT 0.847 (95% CI, 0.772-0.936), readmission 0.871 (95% CI, 0.830-0.917); area under the precision-recall curve—MV 0.137 (95% CI, 0.047-0.175), RRT 0.325 (95% CI, 0.117-0.497), readmission 0.504 (95% CI, 0.388-0.604). Predictions were well calibrated, and the most important features within each model were consistent with clinical intuition. Discussion Our models produce performant, well-calibrated, and interpretable predictions for COVID-19 patients at risk for the target outcomes. They demonstrate the potential to accurately estimate outcome prognosis in resource-constrained care sites managing COVID-19 patients. Conclusions We develop and validate prognostic models targeting MV, RRT, and readmission for hospitalized COVID-19 patients which produce accurate, interpretable predictions. Additional external validation studies are needed to further verify the generalizability of our results.
Coronavirus disease 2019 (COVID-19) patients are at risk for resource-intensive outcomes including mechanical ventilation (MV), renal replacement therapy (RRT), and readmission. Accurate outcome prognostication could facilitate hospital resource allocation. We develop and validate predictive models for each outcome using retrospective electronic health record data for COVID-19 patients treated between March 2 and May 6, 2020.OBJECTIVECoronavirus disease 2019 (COVID-19) patients are at risk for resource-intensive outcomes including mechanical ventilation (MV), renal replacement therapy (RRT), and readmission. Accurate outcome prognostication could facilitate hospital resource allocation. We develop and validate predictive models for each outcome using retrospective electronic health record data for COVID-19 patients treated between March 2 and May 6, 2020.For each outcome, we trained 3 classes of prediction models using clinical data for a cohort of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2)-positive patients (n = 2256). Cross-validation was used to select the best-performing models per the areas under the receiver-operating characteristic and precision-recall curves. Models were validated using a held-out cohort (n = 855). We measured each model's calibration and evaluated feature importances to interpret model output.MATERIALS AND METHODSFor each outcome, we trained 3 classes of prediction models using clinical data for a cohort of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2)-positive patients (n = 2256). Cross-validation was used to select the best-performing models per the areas under the receiver-operating characteristic and precision-recall curves. Models were validated using a held-out cohort (n = 855). We measured each model's calibration and evaluated feature importances to interpret model output.The predictive performance for our selected models on the held-out cohort was as follows: area under the receiver-operating characteristic curve-MV 0.743 (95% CI, 0.682-0.812), RRT 0.847 (95% CI, 0.772-0.936), readmission 0.871 (95% CI, 0.830-0.917); area under the precision-recall curve-MV 0.137 (95% CI, 0.047-0.175), RRT 0.325 (95% CI, 0.117-0.497), readmission 0.504 (95% CI, 0.388-0.604). Predictions were well calibrated, and the most important features within each model were consistent with clinical intuition.RESULTSThe predictive performance for our selected models on the held-out cohort was as follows: area under the receiver-operating characteristic curve-MV 0.743 (95% CI, 0.682-0.812), RRT 0.847 (95% CI, 0.772-0.936), readmission 0.871 (95% CI, 0.830-0.917); area under the precision-recall curve-MV 0.137 (95% CI, 0.047-0.175), RRT 0.325 (95% CI, 0.117-0.497), readmission 0.504 (95% CI, 0.388-0.604). Predictions were well calibrated, and the most important features within each model were consistent with clinical intuition.Our models produce performant, well-calibrated, and interpretable predictions for COVID-19 patients at risk for the target outcomes. They demonstrate the potential to accurately estimate outcome prognosis in resource-constrained care sites managing COVID-19 patients.DISCUSSIONOur models produce performant, well-calibrated, and interpretable predictions for COVID-19 patients at risk for the target outcomes. They demonstrate the potential to accurately estimate outcome prognosis in resource-constrained care sites managing COVID-19 patients.We develop and validate prognostic models targeting MV, RRT, and readmission for hospitalized COVID-19 patients which produce accurate, interpretable predictions. Additional external validation studies are needed to further verify the generalizability of our results.CONCLUSIONSWe develop and validate prognostic models targeting MV, RRT, and readmission for hospitalized COVID-19 patients which produce accurate, interpretable predictions. Additional external validation studies are needed to further verify the generalizability of our results.
Coronavirus disease 2019 (COVID-19) patients are at risk for resource-intensive outcomes including mechanical ventilation (MV), renal replacement therapy (RRT), and readmission. Accurate outcome prognostication could facilitate hospital resource allocation. We develop and validate predictive models for each outcome using retrospective electronic health record data for COVID-19 patients treated between March 2 and May 6, 2020. For each outcome, we trained 3 classes of prediction models using clinical data for a cohort of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2)-positive patients (n = 2256). Cross-validation was used to select the best-performing models per the areas under the receiver-operating characteristic and precision-recall curves. Models were validated using a held-out cohort (n = 855). We measured each model's calibration and evaluated feature importances to interpret model output. The predictive performance for our selected models on the held-out cohort was as follows: area under the receiver-operating characteristic curve-MV 0.743 (95% CI, 0.682-0.812), RRT 0.847 (95% CI, 0.772-0.936), readmission 0.871 (95% CI, 0.830-0.917); area under the precision-recall curve-MV 0.137 (95% CI, 0.047-0.175), RRT 0.325 (95% CI, 0.117-0.497), readmission 0.504 (95% CI, 0.388-0.604). Predictions were well calibrated, and the most important features within each model were consistent with clinical intuition. Our models produce performant, well-calibrated, and interpretable predictions for COVID-19 patients at risk for the target outcomes. They demonstrate the potential to accurately estimate outcome prognosis in resource-constrained care sites managing COVID-19 patients. We develop and validate prognostic models targeting MV, RRT, and readmission for hospitalized COVID-19 patients which produce accurate, interpretable predictions. Additional external validation studies are needed to further verify the generalizability of our results.
Author Sengupta, Soumitra
Elhadad, Noemie
Adelman, Jason
Chen, Ruijun
Pang, Chao
Natarajan, Karthik
Hripcsak, George
Elias, Pierre
Groves, Holden
Green, Robert
Perotte, Adler
Rodriguez, Victor Alfonso
Metitiri, Katherine Schlosser
Mohan, Sumit
Bhave, Shreyas
Author_xml – sequence: 1
  givenname: Victor Alfonso
  surname: Rodriguez
  fullname: Rodriguez, Victor Alfonso
  email: victor.a.rodriguez@columbia.edu
  organization: Department of Biomedical Informatics, Columbia University, New York, New York, USA
– sequence: 2
  givenname: Shreyas
  surname: Bhave
  fullname: Bhave, Shreyas
  organization: Department of Biomedical Informatics, Columbia University, New York, New York, USA
– sequence: 3
  givenname: Ruijun
  orcidid: 0000-0001-5281-4143
  surname: Chen
  fullname: Chen, Ruijun
  organization: Department of Biomedical Informatics, Columbia University
– sequence: 4
  givenname: Chao
  surname: Pang
  fullname: Pang, Chao
  organization: Department of Biomedical Informatics, Columbia University, New York, New York, USA
– sequence: 5
  givenname: George
  surname: Hripcsak
  fullname: Hripcsak, George
  organization: Department of Biomedical Informatics, Columbia University, New York, New York, USA
– sequence: 6
  givenname: Soumitra
  surname: Sengupta
  fullname: Sengupta, Soumitra
  organization: Department of Biomedical Informatics, Columbia University, New York, New York, USA
– sequence: 7
  givenname: Noemie
  surname: Elhadad
  fullname: Elhadad, Noemie
  organization: Department of Biomedical Informatics, Columbia University, New York, New York, USA
– sequence: 8
  givenname: Robert
  surname: Green
  fullname: Green, Robert
  organization: Department of Emergency Medicine, Columbia University Irving Medical Center, New York, New York, USA
– sequence: 9
  givenname: Jason
  surname: Adelman
  fullname: Adelman, Jason
  organization: Division of General Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA
– sequence: 10
  givenname: Katherine Schlosser
  surname: Metitiri
  fullname: Metitiri, Katherine Schlosser
  organization: Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA
– sequence: 11
  givenname: Pierre
  surname: Elias
  fullname: Elias, Pierre
  organization: Department of Biomedical Informatics, Columbia University, New York, New York, USA
– sequence: 12
  givenname: Holden
  surname: Groves
  fullname: Groves, Holden
  organization: Department of Anesthesiology, Columbia University Irving Medical Center, New York, New York, USA
– sequence: 13
  givenname: Sumit
  surname: Mohan
  fullname: Mohan, Sumit
  organization: Division of Nephrology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA
– sequence: 14
  givenname: Karthik
  orcidid: 0000-0002-9066-9431
  surname: Natarajan
  fullname: Natarajan, Karthik
  organization: Department of Biomedical Informatics, Columbia University, New York, New York, USA
– sequence: 15
  givenname: Adler
  surname: Perotte
  fullname: Perotte, Adler
  organization: Department of Biomedical Informatics, Columbia University, New York, New York, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33706377$$D View this record in MEDLINE/PubMed
BookMark eNpNkU1P3DAQhq1qq7LQHnutfOyBgD-SODlWC5SVVuJSUG_R2J4VRo6d2tmV9jfwpwnptnCar3cejeY9JYsQAxLylbMLzlp5-QS9g8toQDPRfiBLXglVtKr8vXiXn5DTnJ8Y47WQ1SdyIqVitVRqSZ6vcI8-Dj2GkUKwdA_eWRhdDDRu6ZDQOjNXfbToM93GRHs0jxCcAU_3057zs_6cJgxTK-HgweBMHB8xwXA4n9EJwfYu51eaC3R197C-KnhLh2l9EufP5OMWfMYvx3hG7m-uf61ui83dz_Xqx6YwFS_HolFcl6psBK80StAgtTQaGatta1ULaE1bc142reYlE2i5tUJXuubKMI1GnpHvf7lDin92mMduusqg9xAw7nInKsZF3VSimaTfjtKd7tF2Q3I9pEP374FvrLgb_k8561696WZvuqM38gUsFIWN
CitedBy_id crossref_primary_10_1016_j_imu_2022_100908
crossref_primary_10_1093_jamia_ocab256
crossref_primary_10_3389_fpubh_2022_993946
crossref_primary_10_1186_s12916_022_02503_0
crossref_primary_10_3389_fpubh_2022_898254
crossref_primary_10_3390_diagnostics14141511
crossref_primary_10_1186_s12879_023_08326_5
crossref_primary_10_1259_bjr_20220058
crossref_primary_10_1002_for_3246
crossref_primary_10_1093_jamia_ocac062
crossref_primary_10_14423_SMJ_0000000000001472
crossref_primary_10_1016_j_ijmedinf_2023_105286
crossref_primary_10_1007_s11739_022_03101_x
crossref_primary_10_3389_fpubh_2023_1227935
crossref_primary_10_1186_s12911_022_01880_z
ContentType Journal Article
Copyright The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association. 2021
The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association.
Copyright_xml – notice: The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association. 2021
– notice: The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association.
DBID TOX
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1093/jamia/ocab029
DatabaseName Oxford Journals Open Access Collection
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: TOX
  name: Oxford Journals Open Access Collection
  url: https://academic.oup.com/journals/
  sourceTypes: Publisher
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1527-974X
EndPage 1488
ExternalDocumentID 33706377
10.1093/jamia/ocab029
Genre Validation Study
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NLM NIH HHS
  grantid: T15 LM007079
– fundername: NHLBI NIH HHS
  grantid: R01 HL148248
– fundername: NLM NIH HHS
  grantid: R01HL148248
– fundername: NLM NIH HHS
  grantid: F31 LM012894
– fundername: NIH HHS
  grantid: F31LM012894
– fundername: NLM NIH HHS
  grantid: 5T15LM007079
GroupedDBID ---
--K
.DC
.GJ
0R~
18M
1B1
1TH
29L
2WC
4.4
48X
53G
5GY
5RE
5WD
6PF
7RV
7X7
7~T
88E
88I
8AF
8AO
8FE
8FG
8FI
8FJ
8FW
AABZA
AACZT
AAEDT
AAJQQ
AALRI
AAMVS
AAOGV
AAPGJ
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAWDT
AAWTL
AAXUO
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABNHQ
ABOCM
ABPQP
ABPTD
ABQLI
ABQNK
ABSMQ
ABUWG
ABVGC
ABWST
ABWVN
ABXVV
ACFRR
ACGFO
ACGFS
ACGOD
ACHQT
ACRPL
ACUFI
ACUTJ
ACVCV
ACYHN
ACZBC
ADBBV
ADGZP
ADHKW
ADHZD
ADIPN
ADJOM
ADMTO
ADMUD
ADNBA
ADNMO
ADQBN
ADRTK
ADVEK
ADYVW
AEGPL
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFQV
AFFZL
AFIYH
AFKRA
AFOFC
AFXAL
AFYAG
AGINJ
AGKRT
AGMDO
AGQXC
AGSYK
AGUTN
AHMBA
AHMMS
AJDVS
AJEEA
AJNCP
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APJGH
AQDSO
AQKUS
AQUVI
ARAPS
ATGXG
AVNTJ
AVWKF
AXUDD
AYCSE
AZQEC
BAWUL
BAYMD
BCRHZ
BENPR
BEYMZ
BGLVJ
BHONS
BKEYQ
BPHCQ
BTRTY
BVRKM
BVXVI
BZKNY
C1A
C45
CCPQU
CDBKE
CS3
DAKXR
DIK
DILTD
DU5
DWQXO
E3Z
EBD
EBS
EIHJH
EJD
EMOBN
ENERS
EO8
EX3
F5P
FDB
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
FYUFA
G-Q
GAUVT
GJXCC
GNUQQ
GX1
H13
HAR
HCIFZ
HMCUK
IH2
IHE
J21
JXSIZ
K6V
K7-
KBUDW
KOP
KSI
KSN
LSO
M0T
M1P
M2P
M2Q
M41
MBLQV
MHKGH
NAPCQ
NOMLY
NOYVH
NQ-
NU-
NVLIB
O9-
OAUYM
OAWHX
OBFPC
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
P62
PAFKI
PCD
PEELM
PHGZT
PQQKQ
PROAC
PSQYO
Q5Y
R53
RIG
ROL
ROX
ROZ
RPM
RPZ
RUSNO
RWL
RXO
S0X
SSZ
SV3
TAE
TEORI
TJX
TMA
TOX
UKHRP
WOQ
WOW
YAYTL
YHZ
YKOAZ
YXANX
ZGI
~S-
AGORE
AHGBF
AJBYB
CGR
CUY
CVF
ECM
EIF
NPM
77I
7X8
ID FETCH-LOGICAL-c514t-871b4748215be3aba3b3cbe006d9d79aedc9611489b1402ed1dd2b5b617c0bec3
IEDL.DBID TOX
ISICitedReferencesCount 19
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000685209200014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1527-974X
IngestDate Thu Oct 02 08:38:28 EDT 2025
Mon Jul 21 06:00:25 EDT 2025
Wed Apr 02 07:06:05 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords COVID-19
supervised machine learning
patient readmission
renal replacement therapy
artificial
respiration
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c514t-871b4748215be3aba3b3cbe006d9d79aedc9611489b1402ed1dd2b5b617c0bec3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-9066-9431
0000-0001-5281-4143
OpenAccessLink https://dx.doi.org/10.1093/jamia/ocab029
PMID 33706377
PQID 2501268528
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_2501268528
pubmed_primary_33706377
oup_primary_10_1093_jamia_ocab029
PublicationCentury 2000
PublicationDate 2021-07-14
PublicationDateYYYYMMDD 2021-07-14
PublicationDate_xml – month: 07
  year: 2021
  text: 2021-07-14
  day: 14
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of the American Medical Informatics Association : JAMIA
PublicationTitleAlternate J Am Med Inform Assoc
PublicationYear 2021
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
SSID ssj0016235
Score 2.4634757
Snippet Abstract Objective Coronavirus disease 2019 (COVID-19) patients are at risk for resource-intensive outcomes including mechanical ventilation (MV), renal...
Coronavirus disease 2019 (COVID-19) patients are at risk for resource-intensive outcomes including mechanical ventilation (MV), renal replacement therapy...
SourceID proquest
pubmed
oup
SourceType Aggregation Database
Index Database
Publisher
StartPage 1480
SubjectTerms Adolescent
Adult
Aged
Aged, 80 and over
Area Under Curve
COVID-19 - complications
COVID-19 - therapy
Electronic Health Records
Female
Humans
Logistic Models
Male
Middle Aged
Models, Statistical
Patient Readmission
Prognosis
Renal Replacement Therapy
Respiration, Artificial
Retrospective Studies
ROC Curve
Statistics, Nonparametric
Young Adult
Title Development and validation of prediction models for mechanical ventilation, renal replacement therapy, and readmission in COVID-19 patients
URI https://www.ncbi.nlm.nih.gov/pubmed/33706377
https://www.proquest.com/docview/2501268528
Volume 28
WOSCitedRecordID wos000685209200014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bS8MwFA46RHzxfpmXEcHHFdemXZpHmQ4Fd3mY0reSyxn0wW60m-Bv8E97ktYhzgdfCoU0afOdnvMl5xJCbowGAUwYj6H690IRStSDQnodBWaqDEeT4JB-5sNhnCRiXO93lH-48AWzBYIyeYuaXXUCm6nnR7EV6MkoWbkL0IZHdQHNtSd-Za6tEUhnSPp7_3-FfbJbk0V6V6F7QDYgPyTbg9odfkQ-f4T8UJkbimKTVYck0dmUzgvb0t25A29KigyVvoFN9rXYUBfrWAXDtWkBdqwCXJSW67HKzfpou66RXBqUCbu5RrOc9kavT_eeL2hdmLU8Ji_9h0nv0atPV_A0kqQFqkFfhTyM0eYrYFJJpphWgH-hEYYLCUaLrl0tCYWLsACMb0ygIoWURyOSmp2QRj7L4YzQrsRFEzcdo6YC6VUglbbeT4hBMG2M3yTXCEE6r-pnpJXfm6VuVtN6VrHNN0Apfo11W8gcZssyRZLmB904CuImOa2QW3XFGEeOxfn5P0a4IDuBDUixVTHDS9JYFEu4Ilv6fZGVRYts8iTG63A8aDnh-gKnk8_V
linkProvider Oxford University Press
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+and+validation+of+prediction+models+for+mechanical+ventilation%2C+renal+replacement+therapy%2C+and+readmission+in+COVID-19+patients&rft.jtitle=Journal+of+the+American+Medical+Informatics+Association+%3A+JAMIA&rft.au=Rodriguez%2C+Victor+Alfonso&rft.au=Bhave%2C+Shreyas&rft.au=Chen%2C+Ruijun&rft.au=Pang%2C+Chao&rft.date=2021-07-14&rft.pub=Oxford+University+Press&rft.eissn=1527-974X&rft.volume=28&rft.issue=7&rft.spage=1480&rft.epage=1488&rft_id=info:doi/10.1093%2Fjamia%2Focab029&rft.externalDocID=10.1093%2Fjamia%2Focab029
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1527-974X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1527-974X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1527-974X&client=summon